Activation of peroxisome proliferator-activated receptor-α and -γ in auricular tissue from heart failure patients

被引:13
作者
Gómez-Garre, D
Herraíz, M
González-Rubio, ML
Bernal, R
Aragoncillo, P
Carbonell, A
Rufilanchas, JJ
Fernández-Cruz, A
机构
[1] UCM, Lab Biol Vasc & Arteriosclerosis Med Nucl Sontano, Dept Pathol, Hosp Clin San Carlos, Madrid 28040, Spain
[2] UCM, Hosp 12 Octubre, Dept Cardiol, Heart Failure & Transplant Unit, Madrid 28040, Spain
关键词
heart failure; atrium; endothelin-1; cardiac remodelling; nuclear receptors;
D O I
10.1016/j.ejheart.2005.06.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Peroxisome proliferator-activated receptors (PPARs), key transcriptional regulators of lipid and energy metabolism in cardiomyocytes, have recently been proposed to modulate cardiovascular pathophysiological responses in experimental models. However, there is little information about the functional activity of PPARs in human heart failure. Aims: To investigate PPAR-alpha and -gamma expression and activity, and the association with ET-1 production and fibrosis, in cardiac biopsies from patients with end-stage heart failure due to ischemic cardiomyopathy (ICM) in comparison and from non-failing donor hearts. All samples were obtained during cardiac transplantation. Methods and results: Morphological analysis (by Masson trichrome and image analysis) did not detect fibrosis in the left atrium from non-failing donors (NFLA) or front lCM patients (FLA). However, left ventricles from failing hearts (FLV) contained a greater number of fibrotic areas (NFLA: 3.21 +/- 1.15, FLA: 1.63 +/- 0.83, FLV: 14.5 +/- 3.45%; n =9, P < 0.05). By RT-PCR, preproET-1 expression was similar in the nonfailing and failing atrium but was significantly higher in the ventricles from failing hearts (NFLA: 1.00 +/- 0.06, FLA: 1.08 +/- 0.11, FLV: 1.74 +/- 0.19; n = 9, P < 0.05). PPAR-alpha and PPAP-gamma mRNA (by RT-PCR) and protein (by Western blot) levels were higher in the ventricles from failing hearts compared with the atrium from failing and non-failing hearts. Electrophoretic mobility shift assays showed that PPAR-alpha and PPAP-gamma were not activated in the ventricles (NFLA: 1.00 +/- 0.11, FLA: 1.89 +/- 0.24, FLV: 0.95 +/- 0.07; n = 9, P < 0.05). Conclusions: These data suggest that PPAR-alpha and PPAP-gamma are selectively activated in the atria from lCM patients and might be functionally important in the maintenance of atrial morphology. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 33 条
  • [1] Peroxisome proliferator-activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo
    Asakawa, M
    Takano, H
    Nagai, T
    Uozumi, H
    Hasegawa, H
    Kubota, N
    Saito, T
    Masuda, Y
    Kadowaki, T
    Komuro, I
    [J]. CIRCULATION, 2002, 105 (10) : 1240 - 1246
  • [2] Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis
    Barbier, O
    Torra, IP
    Duguay, Y
    Blanquart, C
    Fruchart, JC
    Glineur, C
    Staels, B
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : 717 - 726
  • [3] Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway
    Delerive, P
    Martin-Nizard, F
    Chinetti, G
    Trottein, F
    Fruchart, JC
    Najib, J
    Duriez, P
    Staels, B
    [J]. CIRCULATION RESEARCH, 1999, 85 (05) : 394 - 402
  • [4] PPARα activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats
    Diep, QN
    Benkirane, K
    Amiri, F
    Cohn, JS
    Endemann, D
    Schiffrin, EL
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2004, 36 (02) : 295 - 304
  • [5] Peroxisome proliferator-activated receptor α (PPARα) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart
    Finck, BN
    Kelly, DP
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2002, 34 (10) : 1249 - 1257
  • [6] NATRIURETIC PEPTIDES INHIBIT ANGIOTENSIN-II-INDUCED PROLIFERATION OF RAT CARDIAC FIBROBLASTS BY BLOCKING ENDOTHELIN-1 GENE-EXPRESSION
    FUJISAKI, H
    ITO, H
    HIRATA, Y
    TANAKA, M
    HATA, M
    LIN, MH
    ADACHI, S
    AKIMOTO, H
    MARUMO, F
    HIROE, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (02) : 1059 - 1065
  • [7] Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth
    GomezGarre, D
    RuizOrtega, M
    Ortego, M
    Largo, R
    LopezArmada, MJ
    Plaza, JJ
    Gonzalez, E
    Egido, J
    [J]. HYPERTENSION, 1996, 27 (04) : 885 - 892
  • [8] EFFECTS OF ENDOTHELINS ON COLLAGEN TURNOVER IN CARDIAC FIBROBLASTS
    GUARDA, E
    KATWA, LC
    MYERS, PR
    TYAGI, SC
    WEBER, KT
    [J]. CARDIOVASCULAR RESEARCH, 1993, 27 (12) : 2130 - 2134
  • [9] Mechanisms of disease - Signaling pathways for cardiac hypertrophy and failure
    Hunter, JJ
    Chien, KR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (17) : 1276 - 1283
  • [10] Iglarz M, 2003, HYPERTENSION, V42, P737, DOI 10.1161/01.HYP.0000083511.91817.B1